United Therapeutics Corporation (UTHR)

CIK 0001082554 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-05) · 99.1
Q1-2026 8-K (2026-05-06) · 99.1
Latest FY-2025 8-K (2026-02-25) · 99.1
Q3-2025 8-K (2025-10-29) · 99.1
Q2-2025 8-K (2025-07-30) · 99.1
Q1-2025 8-K (2025-04-30) · 99.1
FY-2024 8-K (2025-02-26) · 99.1
Q3-2024 8-K (2024-10-30) · 99.1
Q2-2024 8-K (2024-07-31) · 99.1
Q1-2024 8-K (2024-05-01) · 99.1
FY-2023 8-K (2024-02-21) · 99.1 · 99.2
Q3-2023 8-K (2023-11-01) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Comprehensive Income
Consolidated Statements of Comprehensive Income (P)
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Notes
Accounts Payable and Accrued Expenses
—
Acquisitions
Asset Acquisition
—
Basis of Presentation
—
Business Combination
—
Commitments and Contingencies
—
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Earnings Per Common Share
—
Employee Benefit Plans
—
Fair Value Measurements
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Inventories
—
Investments
Litigation
Organization and Business Description
Pay Vs Performance Disclosure
Priority Review Voucher
—
Property, Plant, and Equipment
—
Recently Issued Accounting Standards
—
Schedule Ii-valuation and Qualifying Accounts
—
Segment Information
Share-based Compensation
Stockholders' Equity
Subsequent Events
—
Summary of Significant Accounting Policies
—